Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Regulator of G protein signaling 9 binding protein (RGS9BP, also called R9AP) is a membrane-anchoring protein expressed in the retina, primarily localized to the outer segments of rod photoreceptors. It forms a complex with RGS9 (regulator of G protein signaling 9) and acts as a membrane anchor, essential for targeting RGS9 to photoreceptor membranes, where it enables rapid termination of the visual signal during phototransduction. Mutations in RGS9BP lead to an inherited retinal disorder characterized by slow recovery of vision after exposure to light (bradyopsia), due to impaired deactivation of phototransduction. RGS9BP is not a drug target or receptor, but a structural regulator required for normal visual adaptation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Regulator of G protein signaling 9 binding protein (RGS9BP).